Eran Rotem
CIK: 0001423145
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLGN
CollPlant Biotechnologies Ltd
Officer
Discretionary Trading P&L
Holdings
About Rotem Eran
Rotem Eran (SEC CIK 0001423145) files insider reports with the SEC as Deputy CEO and CFO of CollPlant Biotechnologies Ltd (CLGN).
Signal8 holds 2 ownership filings by Rotem Eran (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Sep 8, 2026. Those filings report 1 transaction, the latest on Sep 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rotem Eran's filings is in REHOVOT.
Recent filings by Rotem Eran
- Sep 3, 2026: Grant or award of CLGN shares (Form 4, code A).
Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)
- Shlomi Ruty Ben, Director
- Abelis Bar Berta, VP Legal
- Evans Hugh M, Director
- Tal Yehiel, Chief Executive Officer
- Lask Alisa, Director
- Penn Elan, Director